Wibatol-O represents advanced combination therapy featuring 500mg Ornidazole and 250mg Levofloxacin in each film-coated tablet. This pharmaceutical formulation is specifically engi...

Wibatol-O represents advanced combination therapy featuring 500mg Ornidazole and 250mg Levofloxacin in each film-coated tablet. This pharmaceutical formulation is specifically engineered to address complex infections requiring dual-mechanism action against both anaerobic bacteria and protozoal organisms. The careful balance of these active ingredients provides comprehensive coverage against a wide pathogen spectrum, making it essential in modern therapeutic regimens. Manufactured under strict quality control standards, each tablet ensures consistent dosage accuracy and therapeutic reliability for healthcare providers and patients.

The healthcare industry utilizes Wibatol-O across hospitals, clinics, and community health centers. This medication proves particularly valuable in surgical departments, gynecology, gastroenterology, and infectious disease specialties where mixed infections frequently occur. Medical professionals in both public and private healthcare systems depend on this combination therapy for treating complicated infections resistant to single antibiotic approaches. The product meets growing demand for effective combination drugs that address antimicrobial resistance while providing comprehensive treatment solutions.

Businesses selecting Wibatol-O benefit from proven reliability and consistent quality that builds trust with healthcare providers. The dual-action formula offers distinct therapeutic advantages translating to improved patient outcomes and higher treatment success rates. Pharmaceutical distributors and wholesalers can strengthen their product portfolios with this effective combination antibiotic that meets market demand. The product's established efficacy and quality standards provide dependable solutions for medical supply chains serving diverse healthcare settings.

Key Features:
- Precise combination of 500mg Ornidazole and 250mg Levofloxacin per tablet
- Film-coated formulation for easy swallowing and taste masking
- Broad-spectrum coverage against bacterial and protozoal infections
- Manufactured under strict quality control protocols
- Convenient 10-tablet packs for clinical distribution

Benefits:
- Comprehensive treatment of mixed bacterial and protozoal infections
- Enhanced patient compliance through easy-to-swallow film coating
- Reliable therapeutic outcomes with consistent quality standards
- Effective solution for infections resistant to single antibiotics
- Trusted formulation preferred by healthcare professionals